INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,861,610 | -41.5% | 90,500 | -24.6% | 0.04% | -48.8% |
| Q2 2023 | $4,893,600 | +9.4% | 120,000 | 0.0% | 0.09% | 0.0% |
| Q1 2023 | $4,472,400 | +36.3% | 120,000 | +27.6% | 0.09% | +65.4% |
| Q4 2022 | $3,281,405 | -70.8% | 94,050 | -53.2% | 0.05% | -66.7% |
| Q3 2022 | $11,252,000 | +65.7% | 201,106 | +53.3% | 0.16% | +66.0% |
| Q2 2022 | $6,790,000 | -69.9% | 131,180 | -57.8% | 0.09% | -65.3% |
| Q1 2022 | $22,577,000 | +386.0% | 310,700 | +690.9% | 0.27% | +421.2% |
| Q4 2021 | $4,645,000 | -70.5% | 39,286 | -66.6% | 0.05% | -71.1% |
| Q3 2021 | $15,763,000 | -89.7% | 117,500 | -87.5% | 0.18% | -91.0% |
| Q2 2021 | $152,699,000 | +360.7% | 943,100 | +128.4% | 1.99% | +179.9% |
| Q1 2021 | $33,143,000 | +509.1% | 413,001 | +313.0% | 0.71% | +474.2% |
| Q4 2020 | $5,441,000 | – | 100,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |